Your browser doesn't support javascript.
loading
Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study.
Labib, Peter Lz; Russell, Thomas B; Denson, Jemimah L; Puckett, Mark A; Ausania, Fabio; Pando, Elizabeth; Roberts, Keith J; Kausar, Ambareen; Mavroeidis, Vasileios K; Bhogal, Ricky H; Marangoni, Gabriele; Thomasset, Sarah C; Frampton, Adam E; Spalding, Duncan R; Lykoudis, Pavlos; Bellotti, Ruben; Alhaboob, Nassir; Srinivasan, Parthi; Bari, Hassaan; Smith, Andrew; Dominguez-Rosado, Ismael; Croagh, Daniel; Thakkar, Rohan G; Gomez, Dhanny; Silva, Michael A; Lapolla, Pierfrancesco; Mingoli, Andrea; Davidson, Brian R; Porcu, Alberto; Shah, Nehal S; Hamady, Zaed Z; Al-Sarireh, Bilal A; Serrablo, Alejandro; Aroori, Somaiah.
Affiliation
  • Labib PL; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Russell TB; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Denson JL; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Puckett MA; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
  • Ausania F; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Pando E; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Roberts KJ; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Kausar A; East Lancashire Hospital NHS Trust, Blackburn, United Kingdom.
  • Mavroeidis VK; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Bhogal RH; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Marangoni G; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
  • Thomasset SC; NHS Lothian, Edinburgh, United Kingdom.
  • Frampton AE; Royal Surrey NHS Foundation Trust, Guildford, United Kingdom.
  • Spalding DR; Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Lykoudis P; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Bellotti R; Medical University of Innsbruck, Innsbruck, Austria.
  • Alhaboob N; Ibn Sina Specialist Hospital, Khartoum, Sudan.
  • Srinivasan P; King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Bari H; Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan.
  • Smith A; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Dominguez-Rosado I; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Croagh D; Monash Medical Centre, Melbourne, Australia.
  • Thakkar RG; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  • Gomez D; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Silva MA; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Lapolla P; Policlinico Umberto I Sapienza University of Rome, Rome, Italy.
  • Mingoli A; Policlinico Umberto I Sapienza University of Rome, Rome, Italy.
  • Davidson BR; Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Porcu A; Cliniche San Pietro, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.
  • Shah NS; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Hamady ZZ; University Hospital Southampton Foundation Trust, Southampton, United Kingdom.
  • Al-Sarireh BA; Swansea Bay University Health Board, Swansea, United Kingdom.
  • Serrablo A; Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Aroori S; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom; University of Plymouth, Plymouth, United Kingdom. Electronic address: s.aroori@nhs.net.
Eur J Surg Oncol ; 50(6): 108353, 2024 Jun.
Article de En | MEDLINE | ID: mdl-38701690
ABSTRACT

INTRODUCTION:

Patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma (dCCA) often develop cancer recurrence. Establishing timing, patterns and risk factors for recurrence may help inform surveillance protocol strategies or select patients who could benefit from additional systemic or locoregional therapies. This multicentre retrospective cohort study aimed to determine timing, patterns, and predictive factors of recurrence following pancreaticoduodenectomy for dCCA. MATERIALS AND

METHODS:

Patients who underwent pancreaticoduodenectomy for dCCA between June 2012 and May 2015 with five years of follow-up were included. The primary outcome was recurrence pattern (none, local-only, distant-only or mixed local/distant). Data were collected on comorbidities, investigations, operation details, complications, histology, adjuvant and palliative therapies, recurrence-free and overall survival. Univariable tests and regression analyses investigated factors associated with recurrence.

RESULTS:

In the cohort of 198 patients, 129 (65%) developed recurrence 30 (15%) developed local-only recurrence, 44 (22%) developed distant-only recurrence and 55 (28%) developed mixed pattern recurrence. The most common recurrence sites were local (49%), liver (24%) and lung (11%). 94% of patients who developed recurrence did so within three years of surgery. Predictors of recurrence on univariable analysis were cancer stage, R1 resection, lymph node metastases, perineural invasion, microvascular invasion and lymphatic invasion. Predictors of recurrence on multivariable analysis were female sex, venous resection, advancing histological stage and lymphatic invasion.

CONCLUSION:

Two thirds of patients have cancer recurrence following pancreaticoduodenectomy for dCCA, and most recur within three years of surgery. The commonest sites of recurrence are the pancreatic bed, liver and lung. Multiple histological features are associated with recurrence.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs des canaux biliaires / Duodénopancréatectomie / Cholangiocarcinome / Récidive tumorale locale Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Surg Oncol Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs des canaux biliaires / Duodénopancréatectomie / Cholangiocarcinome / Récidive tumorale locale Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Surg Oncol Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni